|
1
|
Nipp RD, Zanconato A, Zheng H, Ferrone CR,
Lillemoe KD, Wo JY, Hong TS, Clark JW, Ryan DP and Fernández-del
Castillo C: Predictors of early mortality after surgical resection
of pancreatic adenocarcinoma in the era of neoadjuvant treatment.
Pancreas. 46:183–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi H, Jin C and Fu D: Preoperative
evaluation of pancreatic ductal adenocarcinoma with synchronous
liver metastasis: Diagnosis and assessment of unresectability.
World J Gastroentero. 22:10024–10037. 2016. View Article : Google Scholar
|
|
4
|
Stark AP, Sacks GD, Rochefort MM, Donahue
TR, Reber HA, Tomlinson JS, Dawson DW, Eibl G and Hines OJ:
Long-term survival in patients with pancreatic ductal
adenocarcinoma. Surgery. 159:1520–1527. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isaji S, Mizuno S, Windsor JA, Bassi C,
Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW,
Kishiwada M, et al: International consensus on definition and
criteria of borderline resectable pancreatic ductal adenocarcinoma
2017. Pancreatology. 18:2–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zaky AM, Wolfgang CL, Weiss MJ, Javed AA,
Fishman EK and Zaheer A: Tumor-Vessel relationships in pancreatic
ductal adenocarcinoma at multidetector CT: Different classification
systems and their influence on treatment planning. Radiographics.
37:93–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Katz MH, Lee SM, Fischer LK,
Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, et
al: superior mesenteric artery margin of posttherapy
pancreaticoduodenectomy and prognosis in patients with pancreatic
ductal adenocarcinoma. Am J Surg Pathol. 39:1395–1403. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denbo JW and Fleming JB: Definition and
management of borderline resectable pancreatic cancer. Surg Clin
North Am. 96:1337–1350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lopez NE, Prendergast C and Lowy AM:
Borderline resectable pancreatic cancer: Definitions and
management. World J Gastroentero. 20:10740–10751. 2014. View Article : Google Scholar
|
|
10
|
Bockhorn M, Uzunoglu FG, Adham M, Imrie C,
Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Büchler M, Charnley
RM, et al: Borderline resectable pancreatic cancer: A consensus
statement by the International Study Group of Pancreatic Surgery
(ISGPS). Surgery. 155:977–988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng Y, Xiu D, Jiang B, Ma Z, Yuan C, Su
J, Shi X, Li L and Tao M: A clinical study about applying different
R1 criteria to evaluate pancreatic head ductal adenocarcinoma
specimens. Zhonghua Wai Ke Za Zhi. 52:834–838. 2014.(In Chinese).
PubMed/NCBI
|
|
12
|
Patel BN, Giacomini C, Jeffrey RB,
Willmann JK and Olcott E: Three-dimensional volume-rendered
multidetector CT imaging of the posterior inferior
pancreaticoduodenal artery: Its anatomy and role in diagnosing
extrapancreatic perineural invasion. Cancer Imaging. 13:580–590.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noto M, Miwa K, Kitagawa H, Kayahara M,
Takamura H, Shimizu K and Ohta T: Pancreas head carcinoma:
frequency of invasion to soft tissue adherent to the superior
mesenteric artery. Am J Surg Pathol. 29:1056–1061. 2005.PubMed/NCBI
|
|
14
|
Mochizuki K, Gabata T, Kozaka K, Hattori
Y, Zen Y, Kitagawa H, Kayahara M, Ohta T and Matsui O: MDCT
findings of extrapancreatic nerve plexus invasion by pancreas head
carcinoma: Correlation with en bloc pathological specimens and
diagnostic accuracy. Eur Radiol. 20:1757–1767. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zuo HD, Tang W, Zhang XM, Zhao QH and Xiao
B: CT and MR imaging patterns for pancreatic carcinoma invading the
extrapancreatic neural plexus (Part II): Imaging of pancreatic
carcinoma nerve invasion. World J Radiol. 4:13–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bonnichon P, Rossat-Mignod JC, Corlieu P,
Aaron C, Yandza T and Chapuis Y: Surgical approach to the superior
mesenteric artery by the Kocher Maneuver: Anatomy study and
clinical applications. Ann Vasc Surg. 1:505–508. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen SJ, Zhang YH, Gu XX, Jiang SJ and Xu
LJ: Yangfei Kongliu Formula, a compound Chinese herbal medicine,
combined with cisplatin, inhibits growth of lung cancer cells
through transforming growth factor-β1 signaling pathway. J Integr
Med. 15:242–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strobel O, Hank T, Hinz U, Bergmann F,
Schneider L, Springfeld C, Jäger D, Schirmacher P, Hackert T and
Büchler MW: Pancreatic cancer surgery: The new R-status counts. Ann
Surg. 265:565–573. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allen PJ, Kuk D, Castillo CF, Basturk O,
Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide
V, He J, et al: Multi-institutional validation study of the
American Joint Commission on Cancer (8th edition) Changes for T and
N staging in patients with pancreatic adenocarcinoma. Ann Surg.
265:185–191. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsumoto I, Murakami Y, Shinzeki M, Asari
S, Goto T, Tani M, Motoi F, Uemura K, Sho M, Satoi S, et al:
Proposed preoperative risk factors for early recurrence in patients
with resectable pancreatic ductal adenocarcinoma after surgical
resection: A multi-center retrospective study. Pancreatology.
15:674–680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Demir IE, Friess H and Ceyhan GO:
Nerve-cancer interactions in the stromal biology of pancreatic
cancer. Front Physiol. 3:972012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jobling P, Pundavela J, Oliveira SM,
Roselli S, Walker MM and Hondermarck H: Nerve-cancer cell
cross-talk: A novel promoter of tumor progression. Cancer Res.
75:1777–1781. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Guo L, Tao M, Fu W and Xiu D:
Parasympathetic neurogenesis is strongly associated with tumor
budding and correlates with an adverse prognosis in pancreatic
ductal adenocarcinoma. Chin J Cancer Res. 28:180–186. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Demir IE, Friess H and Ceyhan GO: Neural
plasticity in pancreatitis and pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 12:649–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ceyhan GO, Bergmann F, Kadihasanoglu M,
Altintas B, Demir IE, Hinz U, Müller MW, Giese T, Büchler MW, Giese
NA and Friess H: Pancreatic neuropathy and neuropathic pain-a
comprehensive pathomorphological study of 546 cases.
Gastroenterology. 136:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ceyhan GO, Demir IE, Rauch U, Bergmann F,
Müller MW, Büchler MW, Friess H and Schäfer K: Pancreatic
neuropathy results in ‘neural remodeling’ and altered pancreatic
innervation in chronic pancreatitis and pancreatic cancer. Am J
Gastroenterol. 104:2555–2565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitsunaga S, Hasebe T, Kinoshita T,
Konishi M, Takahashi S, Gotohda N, Nakagohri T and Ochiai A: Detail
histologic analysis of nerve plexus invasion in invasive ductal
carcinoma of the pancreas and its prognostic impact. Am J Surg
Pathol. 31:1636–1644. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chouat E, Zehani A, Chelly I, Njima M,
Maghrebi H, Bani MA, Njim L, Zakhama A, Haouet S and Kchir N: Tumor
budding is a prognostic factor linked to epithelial mesenchymal
transition in pancreatic ductal adenocarcinoma. Study report and
literature review. Pancreatology. 18:79–84. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ceyhan GO, Demir IE, Maak M and Friess H:
Fate of nerves in chronic pancreatitis: Neural remodeling and
pancreatic neuropathy. Best Pract Res Clin Gastroenterol.
24:311–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Connor K, Li-Chang HH, Kalloger SE,
Peixoto RD, Webber DL, Owen DA, Driman DK, Kirsch R, Serra S,
Scudamore CH, et al: Tumor budding is an independent adverse
prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg
Pathol. 39:472–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L,
Freedland SJ and Frenette PS: Autonomic nerve development
contributes to prostate cancer progression. Science.
341:12363612013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Demir IE, Ceyhan GO, Rauch U, Altintas B,
Klotz M, Muller MW, Büchler MW, Friess H and Schäfer KH: The
microenvironment in chronic pancreatitis and pancreatic cancer
induces neuronal plasticity. Neurogastroenterol Motil. 22:480–490,
e112-e113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo K, Ma Q, Li J, Wang Z, Shan T, Li W,
Xu Q and Xie K: Interaction of the sympathetic nerve with
pancreatic cancer cells promotes perineural invasion through the
activation of STAT3 signaling. Mol Cancer Ther. 12:264–273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kiba T: Relationships between the
autonomic nervous system and the pancreas including regulation of
regeneration and apoptosis: Recent developments. Pancreas.
29:e51–e58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stopczynski RE, Normolle DP, Hartman DJ,
Ying H, DeBerry JJ, Bielefeldt K, Rhim AD, DePinho RA, Albers KM
and Davis BM: Neuroplastic changes occur early in the development
of pancreatic ductal adenocarcinoma. Cancer Res. 74:1718–1727.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sohal DP, Shrotriya S, Glass KT, Pelley
RJ, McNamara MJ, Estfan B, Shapiro M, Wey J, Chalikonda S,
Morris-Stiff G, et al: Predicting early mortality in resectable
pancreatic adenocarcinoma: A cohort study. Cancer. 121:1779–1784.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sinn M, Bahra M, Denecke T, Travis S,
Pelzer U and Riess H: Perioperative treatment options in resectable
pancreatic cancer-how to improve long-term survival. World J
Gastrointest Oncol. 8:248–257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saloman JL, Albers KM, Li D, Hartman DJ,
Crawford HC, Muha EA, Rhim AD and Davis BM: Ablation of sensory
neurons in a genetic model of pancreatic ductal adenocarcinoma
slows initiation and progression of cancer. Proc Natl Acad Sci USA.
113:3078–3083. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Khorana AA, Mangu PB, Berlin J,
Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R,
Shapiro M, et al: Potentially curable pancreatic cancer: American
society of clinical oncology clinical practice guideline. J Clin
Oncol. 34:2541–2556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kurosaki I, Kawachi Y, Nihei K, Tsuchiya
Y, Aono T, Yokoyama N, Shimizu T and Hatakeyama K: Liver perfusion
chemotherapy with 5-Fluorouracil followed by systemic gemcitabine
administration for resected pancreatic cancer: Preliminary results
of a prospective phase 2 study. Pancreas. 38:161–167. 2009.
View Article : Google Scholar : PubMed/NCBI
|
